1 analysts on average are expecting CytRx Corporation to report earnings of $-0.5 per share for the current quarter.
Headlines about CytRx (NASDAQ:CYTR) have been trending somewhat positive on Thursday, Alpha One reports. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road. The average analysts gave this company a mean recommendation of 2.00.
The counter witnessed a trading volume of 0.46 million shares versus an average volume of 0.48 million shares during last trading session.
The stock volatility for week was 7.63% while for month was 13.66%.The stock, as of last close, traded 16.81% to its 52 week low and was changed -87.18% from its 52 week high. The stock presently has an average rating of Buy and an average target price of $1.80. The stock's price is floating in a range of $4.73 and $4.95 whereas, it's 52-week High Price is $5.53 with respect to its 52-week Low Price of $3.74.
CytRx Corporation had its "outperform" rating reiterated by analysts at FBR Capital Markets.
Shares of CytRx Corporation (NASDAQ:CYTR) fell $-0.01 during today's regular trading session, a -2.91% decrease from the previous closing price of $0.43.
CytRx Corporation announced its recent quarter financial results after the market close on 01/01/1970, crushing consensus estimates with both its revenue and earnings.
Maximum and minimum EPS estimate for the current quarter is projected at $-0.5 and $-0.5, respectively, according to 1 analysts.
In the quarter ending March 2016, CytRx Corporation delivered smaller earnings beat. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. CytRx Corporation has a 52-week low of 0.36 and a 52-week high of 3.28. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.
Currently Cytrx Cp (NASDAQ:CYTR)'s shares owned by insiders are 1.7%, whereas shares owned by institutional owners are 17.5%. The stock has a 50 day moving average price of $0.50 and a 200 day moving average price of $0.46. The recommendation scale measures the value from 1 to 5, where 1 means "Strong Buy" and 5 stands for "Sell".
CytRx Corporation has a consensus outperform rating from 1 Wall Street analysts, and the number of shares now sold short amount to at least 18.64% of shares outstanding. The ROA ratio is calculated by comparing net income to average total assets, and is expressed as a percentage.
Daily Ratings & News for Valeant Pharmaceuticals Intl Inc
While taking a look at financials, we can look at a number of key indicators about Valeant Pharmaceuticals International , Inc. Cubist Systematic Strategies Llc stated it has 0.09% of its portfolio in Valeant Pharmaceuticals Intl Inc (NYSE: VRX ).
Bundesliga signs up first woman referee for next season
This shows that in refereeing it is performance that counts", she added. "I'm really looking forward to the task that awaits me". The German Football Association ( DFB ) have confirmed Bibiana Steinhaus will become the country's first-ever female referee.
President Trump to embark on first foreign trip as president
United States officials had warned that acting now could end the President's hopes of reigniting the Middle East peace process. In Trump, however, many Saudis see a decisive, business-focused leader, who they say shares their goals in the region.
Ford to slash 10% of salaried jobs in North America, Asia
To potentially make matters worse-while investors portray Ford as behind the times-the USA auto market is said to have plateaued. The company plans to offer enticing retirement packages to salaried employees to reduce overall headcount, Reuters reports .
Mizuho Reiterates Buy Rating for Western Digital Corp (WDC)
The company reported $0.07 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.04 by $0.03. Following the completion of the transaction, the insider now owns 60,830 shares of the company's stock, valued at $5,495,382.20.
Iran goes to polls to pick President
Iranians are also voting for local councils, with reformists hoping to overturn the conservatives' narrow majority in the capital. Rouhani, 68, is a moderate cleric elected in 2013 on pledges of greater personal freedoms and improved relations with the West.